Cargando…

Adherence to Mass Drug Administration with Dihydroartemisinin–Piperaquine and Plasmodium falciparum Clearance in Southern Province, Zambia

Mass drug administration (MDA) with artemisinin combination therapy is a potentially useful tool for malaria elimination programs, but its success depends partly on drug effectiveness and treatment coverage in the targeted population. As part of a cluster-randomized controlled trial in Southern Prov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Finn, Timothy P., Porter, Travis R., Moonga, Hawela, Silumbe, Kafula, Daniels, Rachel F., Volkman, Sarah K., Yukich, Joshua O., Keating, Joseph, Bennett, Adam, Steketee, Richard W., Miller, John M., Eisele, Thomas P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416972/ https://www.ncbi.nlm.nih.gov/pubmed/32618267 http://dx.doi.org/10.4269/ajtmh.19-0667

Ejemplares similares

Impact of Four Rounds of Mass Drug Administration with Dihydroartemisinin–Piperaquine Implemented in Southern Province, Zambia
por: Eisele, Thomas P., et al.
Publicado: (2020)

Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial
por: Eisele, Thomas P, et al.
Publicado: (2016)

Treatment Coverage Estimation for Mass Drug Administration for Malaria with Dihydroartemisinin–Piperaquine in Southern Province, Zambia
por: Finn, Timothy P., et al.
Publicado: (2020)

Recent Travel History and Plasmodium falciparum Malaria Infection in a Region of Heterogenous Transmission in Southern Province, Zambia
por: Porter, Travis R., et al.
Publicado: (2020)

Cost-Effectiveness of Focal Mass Drug Administration and Mass Drug Administration with Dihydroartemisinin–Piperaquine for Malaria Prevention in Southern Province, Zambia: Results of a Community-Randomized Controlled Trial
por: Yukich, Joshua O., et al.
Publicado: (2020)

Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomized controlled trial
por: Eisele, Thomas P., et al.
Publicado: (2015)

Community-led Responses for Elimination (CoRE): a study protocol for a community randomized controlled trial assessing the effectiveness of community-level, reactive focal drug administration for reducing Plasmodium falciparum infection prevalence and incidence in Southern Province, Zambia
por: Bridges, Daniel J., et al.
Publicado: (2017)

Prevalence of Plasmodium falciparum and Non-falciparum Infections by Photo-Induced Electron Transfer–PCR in a Longitudinal Cohort of Individuals Enrolled in a Mass Drug Administration Trial in Southern Province, Zambia
por: Chishimba, Sandra, et al.
Publicado: (2020)

Measuring Coverage in MNCH: Accuracy of Measuring Diagnosis and Treatment of Childhood Malaria from Household Surveys in Zambia
por: Eisele, Thomas P., et al.
Publicado: (2013)

Dihydroartemisinin‐piperaquine for treating uncomplicated Plasmodium falciparum malaria
por: Zani, Babalwa, et al.
Publicado: (2014)

Population-Wide Malaria Testing and Treatment with Rapid Diagnostic Tests and Artemether-Lumefantrine in Southern Zambia: A community Randomized Step-Wedge Control Trial Design
por: Larsen, David A., et al.
Publicado: (2015)

Costs and cost-effectiveness of a large-scale mass testing and treatment intervention for malaria in Southern Province, Zambia
por: Silumbe, Kafula, et al.
Publicado: (2015)

Estimation of malaria parasite reservoir coverage using reactive case detection and active community fever screening from census data with rapid diagnostic tests in southern Zambia: a re-sampling approach
por: Yukich, Joshua, et al.
Publicado: (2017)

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
por: Phuc, Bui Quang, et al.
Publicado: (2017)

The relative contribution of climate variability and vector control coverage to changes in malaria parasite prevalence in Zambia 2006–2012
por: Bennett, Adam, et al.
Publicado: (2016)

Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
por: Assefa, Ashenafi, et al.
Publicado: (2022)

Blackwater fever in an uncomplicated Plasmodium falciparum patient treated with dihydroartemisinin-piperaquine
por: Lon, Chanthap, et al.
Publicado: (2014)

Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin–piperaquine in the south of Vietnam
por: Thanh, Ngo Viet, et al.
Publicado: (2017)

Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
por: Assefa, Ashenaf, et al.
Publicado: (2023)

A Longitudinal Cohort to Monitor Malaria Infection Incidence during Mass Drug Administration in Southern Province, Zambia
por: Bennett, Adam, et al.
Publicado: (2020)

A methodological framework for the improved use of routine health system data to evaluate national malaria control programs: evidence from Zambia
por: Bennett, Adam, et al.
Publicado: (2014)

Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients
por: Wu, Wanting, et al.
Publicado: (2021)

Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment
por: Omondi, Protus, et al.
Publicado: (2019)

Evaluating the Impact of Programmatic Mass Drug Administration for Malaria in Zambia Using Routine Incidence Data
por: Fraser, Maya, et al.
Publicado: (2020)

Evidence for Reduced Malaria Parasite Population after Application of Population-Level Antimalarial Drug Strategies in Southern Province, Zambia
por: Daniels, Rachel F., et al.
Publicado: (2020)

Dihydroartemisinin-Piperaquine Treatment of Multidrug Resistant Falciparum and Vivax Malaria in Pregnancy
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2014)

Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane(®)) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia
por: Chanda, Pascalina, et al.
Publicado: (2006)

Assessment of the Acceptability of Testing and Treatment during a Mass Drug Administration Trial for Malaria in Zambia Using Mixed Methods
por: Silumbe, Kafula, et al.
Publicado: (2020)

Reductions in Artemisinin-Based Combination Therapy Consumption after the Nationwide Scale up of Routine Malaria Rapid Diagnostic Testing in Zambia
por: Yukich, Joshua O., et al.
Publicado: (2012)

Malaria Infection and Anemia Prevalence in Zambia's Luangwa District: An Area of Near-Universal Insecticide-Treated Mosquito Net Coverage
por: Eisele, Thomas P., et al.
Publicado: (2011)

Case Report: Autoimmune Hemolysis Anemia After Dihydroartemisinin and Piperaquine for Uncomplicated Plasmodium falciparum Malaria
por: Louvois, Marion, et al.
Publicado: (2022)

Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India
por: Gargano, Nicola, et al.
Publicado: (2012)

Failure of dihydroartemisinin-piperaquine treatment of uncomplicated Plasmodium falciparum malaria in a traveller coming from Ethiopia
por: Gobbi, Federico, et al.
Publicado: (2016)

Prevalence of Plasmodium falciparum gametocytaemia in asymptomatic school children before and after treatment with dihydroartemisinin-piperaquine (DP)
por: Dinko, Bismarck, et al.
Publicado: (2023)

Efficacy and safety of dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Papua and Sumatra, Indonesia
por: Asih, Puji B. S., et al.
Publicado: (2022)

Failure of dihydroartemisinin plus piperaquine treatment of falciparum malaria by under-dosing in an overweight patient
por: Roseau, Jean Baptiste, et al.
Publicado: (2016)

Outreach training and supportive supervision for malaria case management in Zambia: the effects of focused capacity building on indicators of diagnostic and clinical performance
por: Worges, Matt, et al.
Publicado: (2018)

Recurrence of Plasmodium malariae and P. falciparum Following Treatment of Uncomplicated Malaria in North Sumatera With Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine
por: Lubis, Inke Nadia D, et al.
Publicado: (2020)

Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children
por: Nambozi, Michael, et al.
Publicado: (2011)

Efficacy of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015
por: Plucinski, Mateusz M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2ca7halfo0706uilarcp9adtt5